Ian Read - Bloomberg

IAN READ

Related Articles

Pfizer Reviewing Idea of Potential Split, CFO Says
1 months ago

Pfizer CEO Was Highest Paid Among Pharma Companies Last Year
1 months ago

Pfizer’s Read Finds Reason to Keep Consumer Health Unit
2 months ago

Pfizer Breakup Talk Stoked by Discount to Drug Stocks
4 months ago

Biggest IPO Since Facebook Tests Pfizer’s Pigs and Dogs Strategy
4 months ago

Pfizer Will Consider Split of Drug Units, CEO Read Says
4 months ago

Megamerger Failures Cloud 2013 Deal Resurgence: Real M&A
4 months ago

Pfizer’s Possible Unit Shuffle Triggers Breakup Concern
4 months ago

Pfizer CEO Must Testify in Chantix Trial, Lawyer Says
6 months ago

Pfizer Profit Matches Estimates as Forcast Range Narrows
7 months ago

Pfizer IPO, Cost Cuts Yield Time to Reinvent Its Research
10 months ago

Pfizer Plans August IPO Filing as Profits Top Estimates
10 months ago

Pfizer Pipeline Bet to Show If Drugmaker Has Blockbuster
13 months ago

Pfizer Says Animal Unit May Be Divested in IPO, Share Swap
13 months ago

Pfizer CEO Read Received 44% Pay Increase With Promotion
15 months ago

Pfizer’s Read Says Animal, Nutritional Decisions ‘On Track’
17 months ago

Pfizer Announces $10 Billion Share Repurchase, Names Read Board Chairman
18 months ago

Pfizer, Apple, Occupy Wall Street: Intellectual Property
19 months ago

Pfizer, Occupy Wall Street, Oliver Smith: Intellectual Property
19 months ago

Pfizer May Market Own Over-the-Counter Lipitor Pill
19 months ago

Show More News

PHOTOS

TOOLS
Watchlist | Stock Finder | Saved